| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |